Navigation Links
PROLOR Biotech Acquires License Option from Yeda for Development of Long-Acting Anti-Obesity Drug
Date:7/27/2009

NES-ZIONA, Israel, July 27, /PRNewswire-FirstCall/ -- PROLOR Biotech, Inc. (OTC Bulletin Board: PBTH) formerly Modigene Inc., today announced that it has entered into an evaluation and option agreement with Yeda Research and Development Company Ltd., the technology transfer arm of the Weizmann Institute of Science. Under the terms of the evaluation and option agreement, PROLOR may obtain from Yeda a license to develop a number of peptide drug candidates, including an anti-obesity peptide, utilizing a delivery technology developed at the Weizmann Institute. The Weizmann Institute of Science is a world-renowned center of natural and exact sciences research and higher learning based in Rehovot, Israel.

"The Weizmann Institute produces world-class research and this agreement, enabling us to access novel technology developed by their scientists, represents an exciting opportunity for PROLOR," said Shai Novik, president of PROLOR. "The first preclinical drug candidate we will evaluate under the agreement is a potential long-acting anti-obesity compound. Obesity represents a large and growing worldwide health care crisis, and there is an urgent need for effective and safe weight loss therapies. We believe the timing is right for us to explore entering this market with a drug candidate that may have strong competitive advantages over other anti-obesity approaches currently in development."

Further details of the agreement were not disclosed.

ABOUT PROLOR BIOTECH

PROLOR Biotech, Inc. is a biopharmaceutical company applying unique technologies, including its patented CTP technology, primarily to develop longer-acting, proprietary versions of already approv
'/>"/>

SOURCE PROLOR Biotech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. PROLOR Biotech Announces $10 Million Preferred Stock Line From Members of The Frost Group
2. PROLOR Biotech Awarded Two U.S. Patents for Its Longer-Acting Human Growth Hormone and Longer-Acting Erythropoietin
3. Oncolytics Biotech Inc. Successfully Completes 100-Litre cGMP Production of REOLYSIN(R)
4. Growing Awareness and Increased Investments Lead to Growth of Biotechnology Applications in the Food & Beverage and Dietary Supplements Sector, Reveals Frost & Sullivan
5. Global One Consulting Announces Exclusive Contract to Expand Saigene Biotech, Inc. Sales in Emerging Markets
6. Axial Biotech Enters Partnership with the University of Utah to Utilize the Utah Population Database to Develop Personalized Diagnostic Tests for Spine Disorders
7. The MedZilla Report: June 2009 Employment Outlook for Biotech/Pharma/Health
8. Oncolytics Biotech(R) Inc. Completes Lyophilization Process for REOLYSIN(R)
9. Dow AgroSciences, NemGenix Establish New Collaboration in Plant Biotechnology
10. Champions Biotechnology Partners with Do-Coop Technologies to Advance Its Novel Oncology Compound Into Biomerk Tumorgraft(TM) Testing
11. Oncolytics Biotech(R) Inc. Research Collaborators Present Glioma Reovirus Research at ASV Annual Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... , KING OF PRUSSIA, Pa., Nov. 30 /PRNews...company specializing in interactive marketing ser...oday announced the launch of its HATCH Consulting...hatch ). Aligning strategic experts across a rang...ng, the HATCH Consulting team is committed to guid...
(Date:11/30/2009)... , BRIARCLIFF MANOR, N.Y., Nov. 30 /PRNews... guidance document for the publication of company-...ine today by the British Medical Journal (BMJ). "T...n of the importance of providing support and guida...ation of study results in the peer-reviewed medica...
(Date:11/30/2009)... , ROCKVILLE, Md., Nov. 30 /PRNewswire-FirstCal...ay it has completed enrollment in the Phase II cli...008/2009 recommended strains) VLP vaccine candidat...r adults). This randomized, double-blind, active-...lity and immunogenicity of two different doses (15...
(Date:11/30/2009)... , BOSTON and COPENHAGEN, Nov. 30 /PRNewswire/...unced today that the Harvard Medical School ICCB-L...nized as a MicroRNA Screening Center of Excellence...l School, and associated hospitals and institution... and RNAi libraries. ,, MicroRNAs are a novel c...
Breaking Biology Technology:Cadient Interactive Announces the Launch of HATCH Consulting Services 2Cadient Interactive Announces the Launch of HATCH Consulting Services 3ISMPP Announces Publication of Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP2 Guidelines Published in the BMJ 2ISMPP Announces Publication of Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP2 Guidelines Published in the BMJ 3NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 3NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 4Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3
...eutics, Inc., a,privately held biopharmaceutical c...porate overview at the UBS Global Life Sciences Co...1:30 p.m. ET at the Grand Hyatt,Hotel., About Hor...a late-stage biopharmaceutical company,focused on ... for the,treatment of mild-to-moderate pain and ar...
... manufacturer of,medical aesthetic lasers, announc...subsidiary of Sanders Morris Harris Group (Nasdaq:...ncing alternatives to fund expansion into,new mark...rected toward expanding the,Aerolase sales channel...rimary care practitioners. This physician group is...
...tments For Women with Endometriosis -, PHOENIX an...irstCall/,-- St. Joseph,s Hospital and Medical Cen...largest healthcare systems in the West with 42 hos...us Biotechnology Inc., (OTC,Bulletin Board: IXSBF;...g,development company commercializing the next gen...
Other Biology Technology:Aerolase Retains SMH Capital Inc. to Advise on Corporate Expansion 2St. Joseph's Hospital and InNexus Biotechnology Enter Collaborative Partnership 2St. Joseph's Hospital and InNexus Biotechnology Enter Collaborative Partnership 3
(Date:11/26/2009)... of the Ocean,s most distinctive residents. ,Every... head shape, says Michelle McComb from Florida At...k,s vision. ,Perhaps their visual field has been e...iving the sharks excellent stereovision and depth ...re two schools of thought on this theory. In 1942,...
(Date:11/26/2009)... 26, 2009) Whitehead researchers have developed a...point specific genes and proteins used by pathogen...ost human cell cultures genes are present in two c...the mother. Gene inactivation by mutation is there...ted, the second copy usually remains active and ta...
(Date:11/25/2009)...d in the stomach, may be used to boost resistance ...e, Yale School of Medicine researchers report in a... of Neuroscience . , Parkinson,s disease is caus...a of the midbrain known as the substantia nigra, w...ced production of dopamine in late-stage Parkinson...
Breaking Biology News(10 mins):Wide heads give hammerheads exceptional stereo view 2Knockouts in human cells point to pathogenic targets 2Hormone ghrelin can boost resistance to Parkinson's disease 2New Study of House Health Reform Bill 3A Iowa Faces Over 24348 Million in Medicare Funded Nursing Home Cuts Over Ten Years 55160 1New Study of House Health Reform Bill 3A Iowa Faces Over 24348 Million in Medicare Funded Nursing Home Cuts Over Ten Years 55160 2First Swedish Patients Receive MitraClip 28R 29 Therapy 55158 1First Swedish Patients Receive MitraClip 28R 29 Therapy 55158 2First Swedish Patients Receive MitraClip 28R 29 Therapy 55158 3Boston Scientific to Webcast Conference Call Discussing Results of Landmark MADIT CRT Trial 13668 1Boston Scientific to Webcast Conference Call Discussing Results of Landmark MADIT CRT Trial 13668 2
... for a species of fish that is a wild swirl of tan...ary to its brethren. So says University of Washing...e new species in the scientific literature and thu...erhaps even more apt given the cockamamie way the ...ntoxicated and should be cited for DUI. , Members...
...ternational collaborators have discovered the key ...n epidemic years cost wheat growers worldwide in e...today in the prestigious journal Science , scient...Zurich and the International Maize and Wheat Impro...e which provides protection against leaf rust, str...
...can be expensive, time-consuming for clinicians, a...ioactivity and subjected to a large number of bloo...e obstacles, relying instead on various blood test...ffer an accurate estimate of a child,s kidney func... a study that will appear in the Journal of the A...
Other Biology News:DNA evidence is in, newly discovered species of fish dubbed H. psychedelica 2DNA evidence is in, newly discovered species of fish dubbed H. psychedelica 3DNA evidence is in, newly discovered species of fish dubbed H. psychedelica 4Saving wheat crops worldwide 2Updated formula measures kidney function more accurately 2Updated formula measures kidney function more accurately 3
...dom EVO96R and Freedom EVO384R are fast multi-chan...t, available in three different sizes, with a mult... deliver significant time saving, with true parall...f your assays with the Freedom EVOware program. ...
Bovine Serum, Sterile Filtered from Meridian Life Science, Inc.
Bromophenol Blue sodium salt from Sigma-Aldrich
Blue Magnet from StemCell Technologies, Inc.
Biology Products: